Literature DB >> 34016268

Precision Medicine Approaches to Cardiac Arrhythmias: JACC Focus Seminar 4/5.

John R Giudicessi1, Michael J Ackerman2, Diane Fatkin3, Jason C Kovacic4.   

Abstract

In the initial 3 papers in this Focus Seminar series, the fundamentals and key concepts of precision medicine were reviewed, followed by a focus on precision medicine in the context of vascular disease and cardiomyopathy. For the remaining 2 papers, we focus on precision medicine in the context of arrhythmias. Specifically, in this fourth paper we focus on long QT syndrome, Brugada syndrome, and atrial fibrillation. The final (fifth) paper will deal with catecholaminergic polymorphic ventricular tachycardia. These arrhythmias represent a spectrum of disease ranging from common to relatively rare, with very different genetic and environmental causative factors, and with differing clinical manifestations that range from almost no consequences to lethality in childhood or adolescence if untreated. Accordingly, the emerging precision medicine approaches to these arrhythmias vary significantly, but several common themes include increased use of genetic testing, avoidance of triggers, and personalized risk stratification to guide the use of arrhythmia-specific therapies.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brugada syndrome; atrial fibrillation; cardiac arrhythmia; genetic testing; genetics; long QT syndrome; precision medicine; sudden cardiac death

Year:  2021        PMID: 34016268     DOI: 10.1016/j.jacc.2021.03.325

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  2 in total

1.  Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.

Authors:  Hao Zhang; James W S Jahng; Yu Liu; Amanda J Chase; Marco V Perez; Joseph C Wu
Journal:  Stem Cell Res       Date:  2021-08-05       Impact factor: 1.587

2.  Plasma growth differentiation factor-15 in patients with "lone" atrial fibrillation.

Authors:  Na Li; Qian Feng; Fangfang Yu; Jian Zhou; Xueyuan Guo
Journal:  J Clin Lab Anal       Date:  2022-03-25       Impact factor: 3.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.